Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.94
+0.36 (2.47%)
At close: Jun 26, 2026, 4:00 PM EDT
14.56
-0.38 (-2.53%)
After-hours: Jun 26, 2026, 6:21 PM EDT
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Janux Therapeutics stock have an average target of 38.44, with a low estimate of 12 and a high estimate of 100. The average target predicts an increase of 157.30% from the current stock price of 14.94.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Janux Therapeutics stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 14 | 14 | 13 | 13 | 13 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 18 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Initiates $80 → $26 | Buy | Initiates | $80 → $26 | +74.03% | Jun 25, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +47.26% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 | Buy | Reiterates | $45 | +201.20% | May 11, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $60 | Buy | Reiterates | $60 | +301.61% | May 8, 2026 |
| Wedbush | Wedbush | Buy Reiterates $45 → $36 | Buy | Reiterates | $45 → $36 | +140.96% | May 8, 2026 |
Financial Forecast
Revenue This Year
31.59M
from 10.00M
Increased by 215.94%
Revenue Next Year
6.95M
from 31.59M
Decreased by -78.00%
EPS This Year
-1.76
from -1.83
EPS Next Year
-2.70
from -1.76
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 68.2M | 35.0M | |
| Avg | 31.6M | 7.0M | |
| Low | 3.7M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 581.6% | 10.8% | |
| Avg | 215.9% | -78.0% | |
| Low | -63.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.81 | -1.80 | |
| Avg | -1.76 | -2.70 | |
| Low | -2.54 | -3.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.